Stocks
Alaunos Therapeutics, Inc.TCRT
NASDAQHealthcareBiotechnology$2.18
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing T cell receptor therapies for solid tumors, with a focus on TCR-T cell treatments targeting cancer-specific antigens. Investors track the stock for its pipeline progress and potential in the immuno-oncology space.
52W Range: $0.72-$4.50
Congressional Interest in Alaunos Therapeutics, Inc. (TCRT)
No congressional trades have been disclosed for Alaunos Therapeutics, Inc. (TCRT) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading TCRT?
No congressional trades found for this stock.